↓ Skip to main content

Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer

Overview of attention for article published in Frontiers in Pharmacology, October 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer
Published in
Frontiers in Pharmacology, October 2020
DOI 10.3389/fphar.2020.544647
Pubmed ID
Authors

Yang Chen, Yun Gao, Xiaojiao Yi, Jinghui Zhang, Zhongjian Chen, Yongjiang Wu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 38%
Professor > Associate Professor 1 13%
Other 1 13%
Student > Master 1 13%
Unknown 2 25%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 13%
Chemical Engineering 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Immunology and Microbiology 1 13%
Medicine and Dentistry 1 13%
Other 0 0%
Unknown 3 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2022.
All research outputs
#2,990,277
of 23,485,296 outputs
Outputs from Frontiers in Pharmacology
#1,220
of 17,044 outputs
Outputs of similar age
#78,158
of 421,013 outputs
Outputs of similar age from Frontiers in Pharmacology
#43
of 462 outputs
Altmetric has tracked 23,485,296 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,044 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,013 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 462 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.